• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

时间到死亡方法揭示 COVID-19 在全球的慢性和严重程度。

Time-to-Death approach in revealing Chronicity and Severity of COVID-19 across the World.

机构信息

Departments of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Department of Biostatistics and Bioinformatics, King Abdullah International Medical Research Center/King Saud bin Abdulaziz University for Health Sciences-MNGHA, Riyadh, Saudi Arabia.

出版信息

PLoS One. 2020 May 12;15(5):e0233074. doi: 10.1371/journal.pone.0233074. eCollection 2020.

DOI:10.1371/journal.pone.0233074
PMID:32396542
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7217458/
Abstract

BACKGROUND

The outbreak of coronavirus disease, 2019 (COVID-19), which started from Wuhan, China, in late 2019, have spread worldwide. A total of 5,91,971 cases and 2,70,90 deaths were registered till 28th March, 2020. We aimed to predict the impact of duration of exposure to COVID-19 on the mortality rates increment.

METHODS

In the present study, data on COVID-19 infected top seven countries viz., Germany, China, France, United Kingdom, Iran, Italy and Spain, and World as a whole, were used for modeling. The analytical procedure of generalized linear model followed by Gompertz link function was used to predict the impact lethal duration of exposure on the mortality rates.

FINDINGS

Of the selected countries and World as whole, the projection based on 21st March, 2020 cases, suggest that a total (95% Cl) of 76 (65-151) days of exposure in Germany, mortality rate will increase by 5 times to 1%. In countries like France and United Kingdom, our projection suggests that additional exposure of 48 days and 7 days, respectively, will raise the mortality rates to10%. Regarding Iran, Italy and Spain, mortality rate will rise to 10% with an additional 3-10 days of exposure. World's mortality rates will continue increase by 1% in every three weeks. The predicted interval of lethal duration corresponding to each country has found to be consistent with the mortality rates observed on 28th March, 2020.

CONCLUSION

The prediction of lethal duration was found to have apparently effective in predicting mortality, and shows concordance with prevailing rates. In absence of any vaccine against COVID-19 infection, the present study adds information about the quantum of the severity and time elapsed to death will help the Government to take necessary and appropriate steps to control this pandemic.

摘要

背景

2019 年 12 月,新型冠状病毒病(COVID-19)在中国武汉爆发,现已在全球范围内蔓延。截至 2020 年 3 月 28 日,全球共报告确诊病例 591971 例,死亡 27090 例。本研究旨在预测 COVID-19 暴露时间长短对病死率增加的影响。

方法

本研究采用广义线性模型分析,利用德国、中国、法国、英国、伊朗、意大利和西班牙以及全球共 7 个 COVID-19 感染人数最多的国家的数据,以及 Gompertz 链接函数进行建模。

结果

在所选择的国家和全球范围内,根据 2020 年 3 月 21 日的病例进行预测,假设德国的暴露时间(95%CI)总计为 76(65-151)天,死亡率将增加 5 倍至 1%。在法国和英国等国家,我们的预测表明,分别增加 48 天和 7 天的暴露时间,将使死亡率提高到 10%。对于伊朗、意大利和西班牙,死亡率将上升到 10%,额外暴露时间为 3-10 天。世界的死亡率将每三周增加 1%。每个国家的致命暴露时间预测间隔与 2020 年 3 月 28 日观察到的死亡率一致。

结论

致命暴露时间的预测在预测死亡率方面显然是有效的,并且与当前的死亡率一致。在没有针对 COVID-19 感染的疫苗的情况下,本研究提供了有关严重程度和死亡时间的信息,这将有助于政府采取必要和适当的措施来控制这一流行疫情。

相似文献

1
Time-to-Death approach in revealing Chronicity and Severity of COVID-19 across the World.时间到死亡方法揭示 COVID-19 在全球的慢性和严重程度。
PLoS One. 2020 May 12;15(5):e0233074. doi: 10.1371/journal.pone.0233074. eCollection 2020.
2
Spatial modeling, risk mapping, change detection, and outbreak trend analysis of coronavirus (COVID-19) in Iran (days between February 19 and June 14, 2020).伊朗2020年2月19日至6月14日期间冠状病毒(COVID-19)的空间建模、风险制图、变化检测及疫情趋势分析
Int J Infect Dis. 2020 Sep;98:90-108. doi: 10.1016/j.ijid.2020.06.058. Epub 2020 Jun 20.
3
Prediction of the COVID-19 Pandemic for the Top 15 Affected Countries: Advanced Autoregressive Integrated Moving Average (ARIMA) Model.预测受 COVID-19 影响最严重的 15 个国家:高级自回归综合移动平均 (ARIMA) 模型。
JMIR Public Health Surveill. 2020 May 13;6(2):e19115. doi: 10.2196/19115.
4
Effect of the social distancing measures on the spread of COVID-19 in 10 highly infected countries.社交距离措施对 10 个高感染国家 COVID-19 传播的影响。
Sci Total Environ. 2020 Nov 10;742:140430. doi: 10.1016/j.scitotenv.2020.140430. Epub 2020 Jun 22.
5
Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.封锁对欧洲和北美 7 个国家的新冠病毒病死率和病毒突变传播的影响。
J Transl Med. 2020 Sep 2;18(1):338. doi: 10.1186/s12967-020-02501-x.
6
Climate and COVID-19 pandemic: effect of heat and humidity on the incidence and mortality in world's top ten hottest and top ten coldest countries.气候与 COVID-19 大流行:高温和高湿度对世界十大最炎热和十大最寒冷国家发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8232-8238. doi: 10.26355/eurrev_202008_22513.
7
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
8
Geographic risk assessment of COVID-19 transmission using recent data: An observational study.利用近期数据进行新冠病毒传播的地理风险评估:一项观察性研究。
Medicine (Baltimore). 2020 Jun 12;99(24):e20774. doi: 10.1097/MD.0000000000020774.
9
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.羟氯喹预防 SARS-CoV-2 感染和妊娠期 COVID-19 疾病严重程度的疗效和安全性(COVID-Preg):一项随机安慰剂对照试验研究方案的结构化总结。
Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.
10
Effect of heat and humidity on the incidence and mortality due to COVID-19 pandemic in European countries.热湿对欧洲国家 COVID-19 大流行发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9216-9225. doi: 10.26355/eurrev_202009_22874.

引用本文的文献

1
Clinical characteristics and predictors of COVID-19 in a community sample from urban areas of Chennai, Southern India.印度南部金奈市区社区样本中新冠病毒病的临床特征及预测因素
Virusdisease. 2023 Dec;34(4):449-455. doi: 10.1007/s13337-023-00843-w. Epub 2023 Oct 10.
2
Transmission dynamics and baseline epidemiological parameter estimates of Coronavirus disease 2019 pre-vaccination: Davao City, Philippines.2019 年冠状病毒病疫苗接种前的传播动态和基本流行病学参数估计:菲律宾达沃市。
PLoS One. 2023 Apr 7;18(4):e0283068. doi: 10.1371/journal.pone.0283068. eCollection 2023.
3
Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event.

本文引用的文献

1
An Epidemiological Study on COVID-19: A Rapidly Spreading Disease.一项关于新型冠状病毒肺炎(COVID-19)的流行病学研究:一种快速传播的疾病。
Cureus. 2020 Mar 18;12(3):e7313. doi: 10.7759/cureus.7313.
2
Forecasting the novel coronavirus COVID-19.预测新型冠状病毒(COVID-19)。
PLoS One. 2020 Mar 31;15(3):e0231236. doi: 10.1371/journal.pone.0231236. eCollection 2020.
3
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.
在一个发生 SARS-CoV-2 超级传播事件的社区中进行病死率影响和血清阳性率调查分析。
Sci Rep. 2023 Apr 3;13(1):5440. doi: 10.1038/s41598-023-32441-7.
4
Tackling the Waves of COVID-19: A Planning Model for Intrahospital Resource Allocation.应对新冠疫情浪潮:医院内部资源分配规划模型
Front Health Serv. 2021 Nov 16;1:718668. doi: 10.3389/frhs.2021.718668. eCollection 2021.
5
Generalized Susceptible-Exposed-Infectious-Recovered model and its contributing factors for analysing the death and recovery rates of the COVID-19 pandemic.用于分析新冠疫情死亡率和康复率的广义易感-暴露-感染-康复模型及其影响因素。
Appl Soft Comput. 2022 Jul;123:108973. doi: 10.1016/j.asoc.2022.108973. Epub 2022 May 11.
6
Acro-ischemic lesions in COVID-19 patients: A case series.新冠肺炎患者的肢端缺血性病变:病例系列
J Cosmet Dermatol. 2022 May;21(5):1822-1829. doi: 10.1111/jocd.14893. Epub 2022 Mar 14.
7
Panel Associations Between Newly Dead, Healed, Recovered, and Confirmed Cases During COVID-19 Pandemic.新冠肺炎大流行期间新死亡、已治愈、已恢复和已确诊病例的面板关联。
J Epidemiol Glob Health. 2022 Mar;12(1):40-55. doi: 10.1007/s44197-021-00019-z. Epub 2021 Dec 11.
8
COVID-19 attributed mortality and ambient temperature: a global ecological study using a two-stage regression model.COVID-19 相关死亡率与环境温度:采用两阶段回归模型的全球生态学研究。
Pathog Glob Health. 2022 Jul;116(5):319-329. doi: 10.1080/20477724.2021.2007336. Epub 2021 Nov 27.
9
Mutual relationships between SARS-CoV-2 test numbers, fatality and morbidity rates.SARS-CoV-2 检测数量、病死率和发病率之间的相互关系。
BMC Public Health. 2021 Nov 2;21(1):1980. doi: 10.1186/s12889-021-12021-y.
10
Leveraging weather data for forecasting cases-to-mortality rates due to COVID-19.利用天气数据预测新型冠状病毒肺炎的病例死亡率。
Chaos Solitons Fractals. 2021 Nov;152:111340. doi: 10.1016/j.chaos.2021.111340. Epub 2021 Aug 18.
九名孕妇感染 COVID-19 的临床特征和宫内垂直传播潜力:病历回顾性研究。
Lancet. 2020 Mar 7;395(10226):809-815. doi: 10.1016/S0140-6736(20)30360-3. Epub 2020 Feb 12.
4
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤:管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
5
Risk of COVID-19 for patients with cancer.癌症患者感染新冠病毒的风险。
Lancet Oncol. 2020 Apr;21(4):e181. doi: 10.1016/S1470-2045(20)30149-2. Epub 2020 Mar 3.
6
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
7
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.冠状病毒病(COVID-19)疫情的流行病学和发病机制。
J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
8
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
9
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS)和新型冠状病毒(COVID-19)疫情,最新和最大的全球健康威胁:我们从中吸取了哪些教训?
Int J Epidemiol. 2020 Jun 1;49(3):717-726. doi: 10.1093/ije/dyaa033.
10
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.